| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SHPRH_0011200 | Exon-Exon | chr6:146247340-146254314 | chr6:145926204-145933178 | 129 nt | 0.4186 |
| hsa_SHPRH_0011300 | Exon-Exon | chr6:146247340-146256299 | chr6:145926204-145935163 | 379 nt | 0.4749 |
| hsa_SHPRH_0011400 | Exon-Exon | chr6:146248325-146276092 | chr6:145927189-145954956 | 2862 nt | 0.4207 |
| hsa_chr6_0217800 | Intergenic-Intergenic | chr6:146253362-146253654 | chr6:145932226-145932518 | 293 nt | 0.3345 |
| hsa_SHPRH_0011600 | Exon-Exon | chr6:146254193-146271618 | chr6:145933057-145950482 | 201 nt | 0.4229 |
| hsa_SHPRH_0011500 | Exon-Exon | chr6:146254193-146275989 | chr6:145933057-145954853 | 2670 nt | 0.4228 |
| hsa_SHPRH_0011700 | Exon-Exon | chr6:146254193-146276077 | chr6:145933057-145954941 | 192 nt | 0.3594 |
| hsa_SHPRH_0012300 | Exon-Exon | chr6:146256216-146256577 | chr6:145935080-145935441 | 164 nt | 0.4268 |
| hsa_SHPRH_0012100 | Exon-Exon | chr6:146256216-146271584 | chr6:145935080-145950448 | 2020 nt | 0.4248 |
| hsa_SHPRH_0012200 | Exon-Exon | chr6:146256216-146275989 | chr6:145935080-145954853 | 2348 nt | 0.4170 |
A review of literature indicates that the circSHPRH is a tumor suppressor in brain cancer, specifically glioblastoma, where it is downregulated and its encoded SHPRH-146aa peptide inhibits glioma growth [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review of human studies indicates that the circSHPRH is downregulated in colorectal cancer tissues and is associated with metastasis and survival, while its overexpression inhibits proliferation and cell cycle progression [Lee et al. DOI:10.1016/j.biopha.2018.12.052].